AbbVie Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (114)

Latest Posts

About This Stock More About This Stock
AbbVie Dividend Stock Analysis
Article By: Dividend Growth Investor
Thursday, September 13, 2018 5:37 PM EDT
The annual dividend per share has increased from $1.60/share in 2013 to $2.56/share in 2017. Based on its most recent dividend increase, the company’s forward annual dividend comes out to $3.84/share.
In this article: ABBV
Read
Options Trades: GRUB, ABBV, SWKS, EPD, VNOM
Article By: Financial Velociraptor
Tuesday, September 4, 2018 5:13 PM EDT
Three positions expired over the weekend and two more were opened.
In this article: GRUB, ABBV, SWKS, VNOM, EPD
Read
My Dirty Dozen Undervalued Dividend Growth Stocks
Article By: Chuck Carnevale
Sunday, August 5, 2018 4:04 AM EDT
Here are12 above-average yielding and currently undervalued dividend growth stocks. The concept of the earnings yield is critically important, and in my personal experience often overlooked or ignored by investors.
In this article: GE, CMI, CVS, GIS, MDP, PFG, RY, SJM, T, VZ, ABBV, IPG, OMC
Read
EC The Top 3 Dividend Paying Spin-Off Stocks Today
Article By: SureDividend
Thursday, August 2, 2018 10:15 PM EDT
We’ve established that stock spin-offs outperform. Let’s review the top 3 dividend paying stocks today for investors interested in spin-offs.
In this article: DOV, ABBV, APY, DXC, PRSP, CLNC, WYND, WH
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich
Saturday, July 28, 2018 9:15 PM EDT
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read

PARTNER HEADLINES

Latest Tweets for $ABBV

No tweets yet!

$ABBV

AbbVie Inc. Increases Humira Prices, Receives FDA Approval For New Drug
Bruce Powers 1/23/2017 6:21:09 PM

Excited to hear the #FDA approved #IMBRUVICA. Should bode very well for $ABBV. And I think it's 8% price hike of #Humira is reasonable (though I realize those taking the drug may disagree).

1 to 1 of 1 comments